Events
Space shortcuts
Space Tools
Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 21 Next »

Session Summary

The use of i2b2 for determining feasibility of clinical studies and clinical trials, focusing on the use of i2b2 in networks across the country, and novel approaches to allowing investigators to perform feasibility studies using i2b2-based client tools.

 

Presenters (4)

 

 

Douglas MacFadden

Chief Informatics Officer

Harvard Catalyst

 

 

 

 

Nich Wattanasin, MS

Corporate Team Lead

Partners HealthCare

 

 

 

 

Jack London, PhD

Research Professor Cancer Biology

Thomas Jefferson University

Director, Informatics Shared Resource

Sidney Kimmel Cancer Center

 

 

 

 

Kavi Wagholikar, PhD

Assistant in Computer Science

Massachusetts General Hospital

 

 

 

Presentations (4)

 

Presentation 1: SHRINE Update

Presenter: Doug MacFadden

 

    • Review of all the new features added to the SHRINE Software

 

 

 

 

 

Presentation 2: Feasibility Studies Using SHRINE and i2b2

Presenter: Nich Wattanasin

 

    • New features added to SHRINE and i2b2 Web Clients to help improve the workflow of identifying and extracting patient sets for clinical studies or trials.

 

 

 

 

Presentation 3: Using i2b2 Data to Determine Clinical Trial Feasibility in the TriNetX Network

Presenter: Jack London


    • Overview of cancer clinical trial accrual problem
    • TriNetX Clinical Research Network and Jefferson University's participation

 

 

 

 


Presentation 4: SMART on FHIR on i2b2

Presenter: Kavi Wagholikar

 


    • New FHIR Cell
    • Standardizing docker containers

 

 

 

 

 

  • No labels